0001209191-20-053925.txt : 20201005
0001209191-20-053925.hdr.sgml : 20201005
20201005203144
ACCESSION NUMBER: 0001209191-20-053925
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201002
FILED AS OF DATE: 20201005
DATE AS OF CHANGE: 20201005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heerma Peter
CENTRAL INDEX KEY: 0001789617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36257
FILM NUMBER: 201225270
MAIL ADDRESS:
STREET 1: C/O RETROPHIN, INC.
STREET 2: 3721 VALLEY CENTRE DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Retrophin, Inc.
CENTRAL INDEX KEY: 0001438533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262383102
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3721 VALLEY CENTRE DR.
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 760-260-8600
MAIL ADDRESS:
STREET 1: 3721 VALLEY CENTRE DR.
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Desert Gateway, Inc.
DATE OF NAME CHANGE: 20080625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-02
0
0001438533
Retrophin, Inc.
RTRX
0001789617
Heerma Peter
C/O RETROPHIN, INC.
3721 VALLEY CENTRE DRIVE, SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
Chief Commercial Officer
Common Stock
2020-10-02
4
S
0
2188
18.90
D
44517
D
Common Stock
2020-10-05
4
S
0
2188
19.35
D
42329
D
The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
Includes 2,705 shares of the Issuer's common stock acquired by the reporting person on May 31, 2020 pursuant to an employee stock purchase program.
/s/ Elizabeth E. Reed, Attorney-in-fact
2020-10-05